Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testing (Q43894346)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2002
edit
Language Label Description Also known as
English
Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testing
scientific article published in January 2002

    Statements

    Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testing (English)
    1 January 2002

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit